Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Short Interest Update

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 16,900 shares, a growth of 16,800.0% from the November 15th total of 100 shares. Based on an average daily trading volume, of 46,600 shares, the days-to-cover ratio is presently 0.4 days.

Awakn Life Sciences Stock Performance

AWKNF remained flat at $0.08 on Wednesday. Awakn Life Sciences has a 52-week low of $0.05 and a 52-week high of $0.19. The firm has a 50 day moving average of $0.08 and a 200-day moving average of $0.09.

About Awakn Life Sciences

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.